You are here: Industry Insights > Advent

News List

Parikh family sells stake in ZCL Chemicals to Advent in Rs 2,000 crore deal expresspharma
March 12, 2021
Parikh Family, founder and promoters of ZCL Chemicals (ZCL) announced that they have sold the entire stake in the company to Advent International (Advent), one of the largest and most experienced global private equity investors ...
Trial to Assess Pulsed Field Ablation System for AFib Receives FDA Conditional Approval americanpharmaceuticalreview
December 18, 2020
FARAPULSE announced the U.S. Food and Drug Administration (FDA) conditionally approved the Company's Investigational Device Exemption (IDE) application to initiate its U.S. pivotal ADVENT trial to evaluate the safety and effectiveness of its ...
Advent International to acquire controlling stake in RA Chem Pharma from Micro Labs expresspharma
July 31, 2020
The transaction is Advent’s sixth investment in the healthcare sector and seventh investment in India over the past twelve months.
Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax contractpharma
May 29, 2020
The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.
Sanofi to sell generics unit for 1.9 billion Euros pharmatimes
July 17, 2018
Global investment group Advent International says it has entered into exclusive negotiations to buy Sanofi’s generics arm Zentiva for 1.9 billion Euros ($2.4 billion).
Advent to Acquire Sanofi's Generics Biz in Europe contractpharma
July 03, 2018
Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi's European generics business, by Advent.
Sanofi, Advent finally shake hands on $2.2B European generics sale fiercepharma
July 02, 2018
It’s official: Sanofi is finally ready to unload its European generics business.